Zusammenfassung
Die frühe fetale Echokardiographie erfordert besondere Kenntnisse der fetalen Herzanatomie, der technischen Limitationen und im Bereich der Transvaginalsonographie. Kongenitale Herzfehler gehören zu den häufigsten angeborenen schweren Fehlbildungen. Die klassischen Indikationen zur fetalen Echokardiographie werden in der frühen Schwangerschaft durch den Nachweis einer verdickten Nackentransparenz ergänzt. Eine verdickte Nackentransparenz ist mit einem höheren Risiko für Herzdefekte assoziiert. Allerdings weisen nur 10–20% der schwereren Herzfehler eine verdickte Nackentransparenz auf, sodass die Entdeckungsraten für Herzfehler weit niedriger liegen als bei der detaillierten Darstellung des Vierkammerblicks im 2. Trimenon und der Kombination von Vierkammerblick- und Ausflusstraktdarstellung im 2. Trimenon. Doppleruntersuchungen des Ductus venosus zwischen der 11. und 14. SSW könnten zusätzlich hilfreich sein. Da strukturelle Anomalien des fetalen Herzens und der großen Gefäße sich erst später im Verlauf der Schwangerschaft manifestieren können, ist auch bei Darstellung einer normalen kardialen Anatomie und normaler Blutflussmuster im Rahmen der frühen Echokardiographie eine weitere Echokardiographie um die 20. SSW erforderlich.
Abstract
The development of high-resolution ultrasound machines with high-frequency transvaginal and transabdominal probes as well as use of color Doppler echocardiography have made it possible to evaluate fetal heart status in detail as early as the end of the first trimester and beginning of the second trimester of pregnancy. Early fetal echocardiography not only requires extensive knowledge of early fetal cardiac anatomy and awareness of technical limitations, but also expertise in the field of transvaginal sonography. These prerequisites are usually only met in specialized centers so that its use is limited to groups at risk of congenital heart abnormalities. The prevalence of congenital heart defects is 5–8 per 1000 live births, making them the most frequent of severe congenital malformations. Because of the high lethality in fetuses with severe deformities, especially chromosomal aberrations and cardiac defects, prevalence during the first trimester is likely to be 15–20 per 1000 fetuses. The classic indications for fetal echocardiography are supplemented by evidence of increased nuchal translucency in early pregnancy since measurement of nuchal translucency between the 11th and 14th week of gestation serves to identify fetuses not only at increased risk of chromosomal anomalies but also of congenital heart defects. The prevalence of defects increases in tandem with nuchal thickness. Increased nuchal translucency thickness is associated with a higher risk of heart defects than many other established indications for echocardiography. Admittedly, however, only 10–20% of severe cardiac defects exhibit increased nuchal translucency during early pregnancy so that the detection rates for cardiac defects are much lower than with a detailed four-chamber view on imaging during the second trimester (40%) and the combination of four-chamber view and imaging of the outflow tract in the second trimester (70%). Doppler examination of the ductus venosus between the 11th and 14th week of gestation can provide additional information since an association between abnormal blood flow patterns in the ductus venosus and cardiac defects in fetuses with increased nuchal translucency and normal karyotype has been described. Since structural anomalies of the fetal heart and the large vessels only become manifest in the later course of pregnancy, even when imaging evidences normal cardiac anatomy and normal blood flow pattern, a further echocardiographic examination is necessary around the 20th week of gestation, as is the case in all indications for echocardiography.
Literatur
Achiron R, Tadmor O, Mashiach S (1991) Heart rate as a predictor of first-trimester spontaneous abortion after ultrasound-proven viability. Obstet Gynecol 78:330–334
Achiron R, Rotstein Z, Lipitz S et al. (1994) First-trimester diagnosis of fetal congenital heart disease by transvaginal ultrasonography. Obstet Gynecol 84:69–72
Achiron R, Weissman A, Rotstein Z et al. (1994) Transvaginal echocardiographic examination of the fetal heart between 13 and 15 weeks gestation in a low-risk population. J Ultrasound Med 13:783–789
Allan L, Sharland G, Chita S et al. (1991) Chromosomal anomalies in fetal congenital heart disease. Ultrasound Obstet Gynecol 1:8–11
Baschat A, Gembruch U, Knöpfle G, Hansmann M (1999) First-trimester fetal heart block: a marker for cardiac anomaly. Ultrasound Obstet Gynecol 14:311–314
Berg C, Geipel A, Smrcek J et al. (2003) Prenatal diagnosis of cardiosplenic syndromes: a 10-year experience. Ultrasound Obstet Gynecol 22:451–459
Bilardo C, Müller M, Zikulnig L et al. (2001) Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 17:288–294
Blaas H, Eik-Nes S, Kiserud T, Hellvik L (1995) Early development of the abdominal wall, stomach and heart from 7 to 12 weeks of gestation: a longitudinal ultrasound study. Ultrasound Obstet Gynecol 6:240–249
Bonnet D, Coltri A, Butera G (1999) Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 23:916–918
Boughman J, Neil C, Ferencz C, Loffredo C (1993) The genetics of congenital heart disease. In: Ferencz C, Rubin J, Loffredo C, Magee C (eds) Epidemiology of congenital heart disease. The Baltimore-Washington Infant Study 1981. Perspect Pediatr Cardiol 4:123–167
Boudjemline Y, Fermont L, Le Bidois J et al. (2001) Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J Pediatr 138:520–524
Bronshtein M, Siegler E, Eshcoli Z, Zimmer EZ (1992) Transvaginal ultrasound measurements of the fetal heart at 11 to 17 weeks of gestation. Am J Perinatol 9:38–42
Bronshtein M, Zimmer E, Gerlis L et al. (1993) Early ultrasound diagnosis of fetal congenital heart defects in high-risk and low-risk pregnancies. Obstet Gynecol 82:225–229
Buskens E, Steyerberg E, Hess J (1997) Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approach. Am J Public Health 87:962–967
Carvalho J, Moscoso G, Ville Y (1998) First-trimester transabdominal fetal echocardiography. Lancet 351:1023–1027
Chaoui R, Gembruch U (1997) Zur Epidemiologie der kongenitalen Herzfehler beim Feten und Neugeborenen. Gynäkologe 30:165–169
Chaoui R, Körner H, Bommer C et al. (1999) Pränatale Diagnostik von Herzfehlern und assoziierte chromosomale Aberrationen. Ultraschall Med 20:177–184
Chinn A, Fitzsimmons J, Shepard T, Fantel A (1989) Congenital heart disease among spontaneous abortuses and stillborn fetuses: prevalence and associations. Teratology 40:477–482
Copel J, Cullen M, Green J et al. (1988) The frequency of aneuploidy in prenatally diagnosed congenital heart disease: an indication for fetal karyotyping. Am J Obstet Gynecol 158:409–413
Devine P, Simpson L (2000) Nuchal translucency and its relationship to congenital heart disease. Semin Perinatol 24:343–351
Dolkart L, Reimers F (1991) Transvaginal fetal echocardiography in early pregnancy: normative data. Am J Obstet Gynecol 165:688–691
Driscoll D (1994) Genetic basis of DiGeorge and velocardiofacial syndromes. Curr Opin Pediatr 6:702–706
Favre R, Cherif Y, Kohler M, Kohler A et al. (2003) The role of fetal nuchal translucency and ductus venosus Doppler at 11–14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol 21:239–243
Ferencz C, Neill C, Boughman J et al. (1989) Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr 114:79–86
Ferencz C, Rubin J, Loffredo C, Magee C (1993) Epidemiology of congenital heart disease: the Baltimore-Washington-Infant-Study 1981–1989. Futura, Mount Kisco, NY
Gembruch U, Knöpfle G, Chatterjee M et al. (1990) First trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography. Obstet Gynecol 75:496–498
Gembruch U, Knöpfle G, Bald R, Hansmann M (1993) Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 3:310–317
Gembruch U (1997) Prenatal diagnosis of congenital heart disease. Prenat Diagn 17:1283–1297
Gembruch U, Chaoui R (1997) Möglichkeiten und Grenzen eines Screeningprogrammes. Gynäkologe 30:191–199
Gembruch U, Smrcek J (1997) The prevalence and clinical significance of tricuspid valve regurgitation in normally grown fetuses and those with intrauterine growth retardation. Ultrasound Obstet Gynecol 9:1–9
Gembruch U, Shi C, Smrcek J (2000) Biometry of the fetal heart between 10 and 17 weeks of gestation. Fetal Diagn Ther 15:20–31
Gembruch U, Geipel A (2003) Indication for fetal echocardiography: screening in low- and high-risk populations. In: Yagel S, Silverman N, Gembruch U (eds) Fetal cardiology. Thomson Publishing Services, Andover, pp 89–106
Gerlis L (1985) Cardiac malformations in spontaneous abortions. Int J Cardiol 7:29–46
Germer U, Baschat A, Gembruch U (1997) Frühe fetale Echokardiographie. Gynäkologe 30:200–209
Ghi T, Huggon I, Zosmer N, Nicolaides K (2001) Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 18:610–614
Haak M, Twisk J, Van Vugt J (2002) How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol 20:9–13
Hoffman J, Christianson R (1978) Congenital heart disease in a cohort of 19.502 birth with longterm follow-up. Am J Cardiol 42:641–647
Hoffman J (1990) Congenital heart disease: incidence and inheritance. Pediatr Clin North Am 37:25–43
Hoffman J (1994) Reflections on the past, present, and future of paediatric cardiology. Cardiol Young 4:208–223
Hyett J, Moscoso G, Papapanagiotou G et al. (1996) Abnormalities of the fetal heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11–13 weeks of gestation. Ultrasound Obstet Gynecol 7:245–250
Hyett J, Noble P, Snijders R et al. (1996) Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 7:239–244
Hyett J, Perdu M, Sharland G et al. (1997) Increased nuchal translucency at 10–14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 10:242–246
Hyett J, Perdu M, Sharland G et al. (1999) Using fetal nuchal translucency to screen for major cardiac defects at 10–14 weeks of gestation: population based cohort study. BMJ 318:81–85
Koren G, Edward M, Miskin M (1987) Antenatal sonography of fetal malformations associated with drugs and chemicals: a guide. Am J Obstet Gynecol 156:79–85
Lopes L, Brizot M, Lopes M et al. (2003) Structural and functional cardiac abnormalities identified prior to 16 weeks‘ gestation in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 22:470–478
Matias A, Huggon I, Areias J et al. (1999) Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus flow at 10–14 weeks. Ultrasound Obstet Gynecol 14:307–310
Matsuoka R, Takao A, Kimura M et al. (1994) Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11. Am J Med Genet 53:285–289
Mavrides E, Cobian-Sanchez F, Tekay A et al. (2001) Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 17:106–110
Mennicke K, Schwinger E (1997) Genetische Aspekte kongenitaler fetaler Herzerkrankungen. Gynäkologe 30:181–189
Nicolaides K, Snijders R, Gosden C et al. (1992) Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 340:704–707
Nora J, Nora A (1988) Update on counselling the family with a first degree relative with a congenital heart defect. Am Med Genet 29:137–142
Nora J (1993) Causes of congenital heart diseases: old and new modes, mechanisms, and models. Am Heart J 125:1409–1419
Pandya P, Kondylios A, Hilbert L et al. (1995) Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 5:15–19
Payne R, Johnson M, Grant J, Strauss A (1995) Toward a molecular understanding of congenital heart disease. Circulation 91:494–504
Porat S, Anteby E, Hamani Y, Yagel S (2003) Fetal supraventricular tachycardia diagnosed and treated at 13 weeks of gestation: a case report. Ultrasound Obstet Gynecol 21:302–305
Rustico M, Benettoni A, D’Ottavio G et al. (2000) Early screening for fetal cardiac anomalies by transvaginal echocardiography in an unselected population: the role of operator experience. Ultrasound Obstet Gynecol 16:614–619
Schwärzler P, Carvalho J, Senat M et al. (1999) Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10–14 weeks of gestation as part of routine antenatal care in an unselected population. J Obstet Gynecol 106:1029–1034
Shapiro I, Degani S, Leobovitz Z et al. (1998) Fetal cardiac measurements derived by transvaginal and transabdominal cross-sectional echocardiography from 14 weeks of gestation to term. Ultrasound Obstet Gynecol 12:404–418
Smrcek J, Germer U, Gembruch U (1998) Functional pulmonary valve regurgitation in the fetus. Ultrasound Obstet Gynecol 12:254–259
Smrcek J, Gembruch U (1999) Longitudinal observations in normally grown fetuses with tricuspid valve regurgitation: report of 22 cases. Prenat Diagn 19:197–204
Smrcek J, Gembruch U, Krokowski M et al. (2003) The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy. Arch Gynecol Obstet 268:94–101
Souka A, Snijders R, Novakow A et al. (1998) Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 11:391–400
Souka A, Krampl E, Bakalis S et al. (2001) Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 18:9–17
Tworetzki W, McElhinnery D, Reddy V et al. (2001) Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 103:1269–1273
Ursell P, Byrne J, Strobino B (1985) Significance of cardiac defects in the developing fetus: a study of spontaneous abortuses. Circulation 72:1232–1236
Verheijen P, Lisowski L, Stoutenbeek P (2001) Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Thorac Cardiovasc Surg 121:798–803
Wisser J, Dirschedl P (1994) Embryonic heart rate in dated human embryos. Early Hum Dev 37:107–115
Yagel S, Weismann A, Rotstein Z et al. (1997) Congenital heart defects: natural course and in utero development. Circulation 96:550–555
Yagel S, Cohen S, Achiron R (2001) Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 17:367–369
Yoo S, Lee Y, Kim E (1997) Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol 9:173–182
Yoo S, Young H, Kyoung S (1999) Abnormal three-vessel view on sonography: a clue to the diagnosis of congenital heart disease in the fetus. Am J Roentgenol 172:825–830
Zerres K, Gembruch U, Schwanitz G et al. (1990) Fetale Echokardiographie und klinische Genetik—eine enge Wechselbeziehung. Z Kardiol 79:96–106
Zosmer N, Souter V, Chan C et al. (1999) Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynecol 106:829–833
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smrcek, J., Krapp, M., Axt-Fliedner, R. et al. Frühe fetale Echokardiographie. Gynäkologe 37, 716–724 (2004). https://doi.org/10.1007/s00129-004-1568-x
Issue Date:
DOI: https://doi.org/10.1007/s00129-004-1568-x
Schlüsselwörter
- Frühe fetale Echokardiographie
- Fetales Herz
- Kongenitale Herzdefekte
- Transvaginalsonographie
- Verdickte Nackentransparenz